View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Man Group PLC : Form 8.3 - Smith (DS) plc

Man Group PLC : Form 8.3 - Smith (DS) plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION (a)   Full name of discloser:Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)   Name of offeror/offeree in relation to whose relevant securities this...

 PRESS RELEASE

Global Water Resources Declares Monthly Dividend

Global Water Resources Declares Monthly Dividend PHOENIX, March 28, 2024 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, has declared, under its dividend policy a monthly cash dividend in the amount of $0.02508 per common share (an annualized dividend rate of $0.30096 per share). The dividend will be payable on April 30, 2024, to holders of record at the close of business on April 16, 2024. About Global Water Resources Global Water Resources, Inc. is a leading water resource management company that owns and operates 30 syst...

 PRESS RELEASE

Reborn Coffee Reports Fiscal Year 2023 Financial Results

Reborn Coffee Reports Fiscal Year 2023 Financial Results FY 2023 Record Revenue Increased 84% to $6.0 Million FY 2023 Gross Profit Increased 93% to $1.9 Million BREA, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Reborn Coffee, Inc. (NASDAQ: REBN) ("Reborn", or the "Company"), a California-based retailer of specialty coffee, has reported its financial and operational results for the fiscal year ended December 31, 2023. Key Financial and Operational Highlights Revenue increased 109% to $1.8 million in Q4'23 from $0.9 million in Q4'22.Revenue increased 84% to $6.0 million in FY'23 ...

 PRESS RELEASE

ReShape Lifesciences® Receives Notice of Allowance for Additional U.S....

ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System Patent Significantly Strengthens Intellectual Property Portfolio IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent application 18/370,819, entitled, “Intragastric Device.” When issued, the patent will cover claims for an intrag...

 PRESS RELEASE

First Quantum Provides Notice of First Quarter 2024 Results

First Quantum Provides Notice of First Quarter 2024 Results TORONTO, March 28, 2024 (GLOBE NEWSWIRE) -- First Quantum Minerals Ltd. (“First Quantum” or “the Company”) (TSX: FM) will release first quarter 2024 financial and operating results on Tuesday, April 23, 2024 after the close of the Toronto Stock Exchange. The Company will host a conference call and webcast to discuss the results on Wednesday, April 24, 2024 at 9:00 am (EST). Conference call and webcast details:Toll-free North America: 1-800-319-4610Toll-free International: Webcast: Direct or on our A replay of the webcast wi...

 PRESS RELEASE

Grab Files Annual Report on Form 20-F for Fiscal Year 2023

Grab Files Annual Report on Form 20-F for Fiscal Year 2023 NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Grab Holdings Limited (NASDAQ: GRAB)(“Grab” or the “Company”), Southeast Asia’s leading superapp, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the Securities and Exchange Commission on March 28, 2024. The annual report can be accessed via the SEC's website at and the Company’s investor relations website at /. The Company will provide a hard copy of its annual report containing the audited consolidated financial statement...

 PRESS RELEASE

AB Traction: Traction publicerar årsredovisningen och årsberättelsen f...

AB Traction: Traction publicerar årsredovisningen och årsberättelsen för 2023 AB Traction: Traction publicerar årsredovisningen och årsberättelsen för 2023 Tractions årsredovisning och årsberättelse för 2023 är nu offentliggjorda och finns tillgängliga på bolagets webbplats,  Den tryckta versionen av årsberättelsen kan beställas genom e-post till . AB Traction Petter StillströmVerkställande direktörTel: 08-506 289 00 DENNA INFORMATION ÄR SÅDAN INFORMATION SOM AB TRACTION ÄR SKYLDIGT ATT OFFENTLIGGÖRA ENLIGT LAGEN OM VÄRDEPAPPERSMARKNADEN. INFORMATIONEN LÄMNADES FÖR OFFENTLIGGÖRANDE DEN...

 PRESS RELEASE

Bannix and GBT Partner to Bring Revolutionary Imaging Tech "VisionWave...

Bannix and GBT Partner to Bring Revolutionary Imaging Tech "VisionWave" to Market Enter into Binding Business Combination Agreement WEST HOLLYWOOD, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Bannix Acquisition Corp. (“Bannix” or the “Company”) together with GBT Technologies, Inc. (“GBT”), announced today that the Company and VisionWave Technologies Inc., which is partially owned by GBT (“VisionWave”) have executed a binding Business Combination Agreement (“BCA”) with the goal of bringing a groundbreaking imaging technology called “VisionWave” to market. This technology platform, backed ...

 PRESS RELEASE

Nexalin Technology Announces Positive Results of Clinical Study Valida...

Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego Collaborative Study involving the VA and UCSD achieved statistically significant decrease in PCS and PTSD symptoms versus control group The data supports the Company’s strategy to offer military and civilian physicians a new tool to effectively treat mTBI without the use of medication, and without side effects or adverse events HOUSTON, TEXAS, March 28, 2024 (GLOBE NEWSWIRE) -- Ne...

 PRESS RELEASE

Tenax Therapeutics Provides Business and Clinical Development Updates ...

Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results First Patient Enrolled in Phase 3 LEVEL Trial Evaluating TNX-103 (oral levosimendan) for the Treatment of Pulmonary Hypertension from Heart Failure with Preserved Ejection Fraction (PH-HFpEF)Expansion of U.S. Intellectual Property Covering the Use of Levosimendan for the Treatment of PH-HFpEF and for Use in Combination with Other Cardiovascular Therapies The Company Secured Global Commercial Rights to Levosimendan for the Treatment of PH-HFpEFThe Company will host a KOL Event, “LEVEL ...

 PRESS RELEASE

SweetWater Brewing Launches Hammer Red Amber Ale to Support Georgia Aq...

SweetWater Brewing Launches Hammer Red Amber Ale to Support Georgia Aquarium The Limited-Release Seasonal Is Part of SweetWater’s On-going Partnership with Georgia Aquarium ATLANTA, March 28, 2024 (GLOBE NEWSWIRE) -- (“SweetWater Brewing” or “SweetWater”), the largest craft brewer in the Southeast and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), announced today the release of its new Hammer Red Amber Ale, the latest collaboration beer as part of its partnership with Georgia Aquarium. A portion of sales of the limited-release beer will be donated to Georgia Aquarium...

 PRESS RELEASE

CervoMed Announces Up to $149.4 Million Private Placement Financing Jo...

CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors Funding from new investors, including RA Capital Management, Armistice Capital, Special Situations Funds and Soleus Capital $50 million financing upfront with up to an additional $99.4 million tied to exercise of warrants Pro forma cash and cash equivalents from upfront proceeds expected to provide runway through the end of 2025 BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for age-related neurolo...

 PRESS RELEASE

BOS Reports Financial Results for the Fourth Quarter and the Year 2023

BOS Reports Financial Results for the Fourth Quarter and the Year 2023 Exceeds the projections for 2023 and positive outlook for year 2024 RISHON LE ZION, Israel, March 28, 2024 (GLOBE NEWSWIRE) -- BOS Better Online Solutions Ltd. ("BOS" or the "Company") (NASDAQ: BOSC) reported its financial results for the fourth quarter and the year 2023. Year 2023 Financial Highlights: Revenues grew by 6.5% to $44.2 million from $41.5 million in the year 2022 ;Operating profit increased to $2.5 million from $1.9 million in the year 2022;EBITDA amounted to $3.06 mill...

 PRESS RELEASE

Kenorland Minerals Announces Termination of Tanacross Project Earn-in ...

Vancouver, British Columbia--(Newsfile Corp. - March 28, 2024) - Kenorland Minerals Ltd. (TSXV: KLD) (OTCQX: KLDCF) (FSE: 3WQ0) ("Kenorland" or the "Company") announces that Antofagasta PLC ("Antofagasta") has terminated the Tanacross earn-in option to joint venture agreement dated July 19, 2022 (the "Option Agreement") and Kenorland remains the 100% owner of the Tanacross Project (the "Project"), located in Eastern Alaska, USA.Zach Flood, President and CEO states, "We greatly appreciate the efforts made by Antofagasta to advance the Tanacross Project with us over the last two years. During th...

 PRESS RELEASE

First Quantum Provides Notice of Annual General Meeting of Shareholder...

First Quantum Provides Notice of Annual General Meeting of Shareholders and Filing of Annual Disclosure Documents TORONTO, March 28, 2024 (GLOBE NEWSWIRE) -- First Quantum Minerals Ltd. (“First Quantum” or the “Company”) (TSX: FM) provides notice that the Annual General Meeting of shareholders of the Company will take place on May 9, 2024 at 9:00 am (EDT) online via audio webcast through the Company’s website () or directly at . ANNUAL DISCLOSURE DOCUMENTS The Company’s 2023 Annual Report (which includes the Company’s audited annual financial statements for the year ended December 31, 2...

 PRESS RELEASE

Bridgeline Releases Zeus Update with Concept and Image Search

Bridgeline Releases Zeus Update with Concept and Image Search WOBURN, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of marketing software, announced that Smart Search by HawkSearch, featuring AI powered concept and image search with Generative AI (GenAI) capabilities, is now available to the general public.         Smart Search leverages the latest advancements in AI, including large language models (LLMs) and vector databases, to empower online shopping search functionality. Smart Search includes three capabilities: Concept SearchImag...

 PRESS RELEASE

SRM announces Sip with Me cups Reorder

SRM announces Sip with Me cups Reorder JUPITER, FL, March 28, 2024 (GLOBE NEWSWIRE) -- , (Nasdaq: SRM) (the “Company” or “SRM”) announced it has received an 18,000+ piece assorted Sip With Me Cup re-order with a retail value of approximately $275,000. The order from one of SRM’s Orlando theme park customers, that has been in business more than fifty years and welcomes more than four million guests per year, continues to be a great venue for SRM to introduce its patented Sip With Me cups to our target audience. “Growing SRM and establishing Sip With Me as a fan favorite continues to be ...

 PRESS RELEASE

CISO Global Enters into Exclusive Agreement With Fortegra

CISO Global Enters into Exclusive Agreement With Fortegra Global cybersecurity provider and multinational specialty insurer join forces to uniquely provide cyber warranty protection for CISO Global clients Scottsdale, Ariz., March 28, 2024 (GLOBE NEWSWIRE) --  (NASDAQCM: CISO), an industry leader in proprietary software, managed cybersecurity, and compliance, and The Fortegra Group, Inc. (“Fortegra”), a multinational specialty insurance company, have entered into an exclusive agreement to provide product protection plans for CISO Global cybersecurity clients via Fortegra’s P&C Group ...

 PRESS RELEASE

TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as...

TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer Medical oncologist brings over 25 years of industry experience to lead Clinical Development Strategy BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, announced today that Daniel Vlock, M.D., has been appointed as the company’s Chief Medical Officer. Dr. Vlock is a medical oncologist with over 25 years of industry experience and 15 years in academia, including ren...

 PRESS RELEASE

Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Dir...

Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced the appointment of Geoff McDonough, M.D., to its Board of Directors. “Geoff is an outstanding addition to our board, bringing broad operational leadership and a depth of clinical and commercial experience that will benefit our work greatly as we advance our lead product candidate, THB335, into clinical tr...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch